AMERICAN RENAL ASSOCIATES HOLDINGS, INC.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

7 filing records in this dataset, filed from 2011-07-22 to 2012-11-09. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-19; this is not a statement that none were filed.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Short annual reporting periods

These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.

Reported figures
MeasurePeriodValue
Capital expenditure2010-05-08 – 2010-12-3113804000 USD Source Dispute
Net income2010-05-08 – 2010-12-31-9763000 USD Source Dispute
Operating cash flow2010-05-08 – 2010-12-3125943000 USD Source Dispute
Operating expenses2010-05-08 – 2010-12-31181519000 USD Source Dispute
Operating income2010-05-08 – 2010-12-3121242000 USD Source Dispute

Latest quarter

Revenue

92.7 million USD

2011-09-30 · USD

Exact inputs and evidence

Operating margin

23.94%

2011 Q3 · %

Exact inputs and evidence
  • Operating Income: 22188000 USD Source
  • Revenue: 92666000 USD Source

Operating cash flow

36.4 million USD

2011-09-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: 63059000 USD Source
  • Operating Cash Flow: 26663000 USD Source

Free cash flow

30.7 million USD

2011-09-30 · USD

Exact inputs and evidence
  • Operating Cash Flow: 63059000 USD Source
  • Operating Cash Flow: 26663000 USD Source
  • Capital Expenditure: 14559000 USD Source
  • Capital Expenditure: 8827000 USD Source
Cash and cash equivalents
36.8 million USD Source
Exact value

36774000 USD

Long-term debt including current maturities
419 million USD
Exact inputs and evidence

418973000 USD

  • Long-term debt including current maturities: 418973000 USD Source
Shares outstanding
9.22 million shares Source
Exact value

9215594 shares

Reported share-count change

4.01% · 355 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 8860501 shares · 2011-09-30· Source
  • 9215594 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Operating cash flow

94.3 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence
  • Operating cash flow: 79642000 USD · 2011-01-01 – 2011-12-31 Source
  • Operating cash flow: 63059000 USD · 2011-01-01 – 2011-09-30 Source
  • Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
  • Operating cash flow: 45233000 USD · 2012-01-01 – 2012-06-30 Source
  • Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
  • Operating cash flow: 77695000 USD · 2012-01-01 – 2012-09-30 Source
  • Operating cash flow: 45233000 USD · 2012-01-01 – 2012-06-30 Source

Capital expenditure

27.9 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence
  • Capital expenditure: 21908000 USD · 2011-01-01 – 2011-12-31 Source
  • Capital expenditure: 14559000 USD · 2011-01-01 – 2011-09-30 Source
  • Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
  • Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source
  • Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
  • Capital expenditure: 20582000 USD · 2012-01-01 – 2012-09-30 Source
  • Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source

Free cash flow

66.3 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence
  • Operating cash flow: 79642000 USD · 2011-01-01 – 2011-12-31 Source
  • Operating cash flow: 63059000 USD · 2011-01-01 – 2011-09-30 Source
  • Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
  • Operating cash flow: 45233000 USD · 2012-01-01 – 2012-06-30 Source
  • Operating cash flow: 23846000 USD · 2012-01-01 – 2012-03-31 Source
  • Operating cash flow: 77695000 USD · 2012-01-01 – 2012-09-30 Source
  • Operating cash flow: 45233000 USD · 2012-01-01 – 2012-06-30 Source
  • Capital expenditure: 21908000 USD · 2011-01-01 – 2011-12-31 Source
  • Capital expenditure: 14559000 USD · 2011-01-01 – 2011-09-30 Source
  • Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
  • Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source
  • Capital expenditure: 6133000 USD · 2012-01-01 – 2012-03-31 Source
  • Capital expenditure: 20582000 USD · 2012-01-01 – 2012-09-30 Source
  • Capital expenditure: 14483000 USD · 2012-01-01 – 2012-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-09.

Financial data available through: 2011-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 1 of 11 periods available· newest 2011-12-31
  • Net income: 1 of 11 periods available· newest 2011-12-31
  • Operating cash flow: 1 of 11 periods available· newest 2011-12-31
  • Capital expenditure: 1 of 11 periods available· newest 2011-12-31
  • Total assets: 1 of 11 periods available· newest 2011-12-31
  • liabilities: No compatible figures in this window
  • Current assets: 1 of 11 periods available· newest 2011-12-31
  • Current liabilities: 1 of 11 periods available· newest 2011-12-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2011-12-31
  • Long-term debt including current maturities: 1 of 11 periods available· newest 2011-12-31
  • Shares outstanding: 1 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2011 2011-01-01 – 2011-12-31
USD 2.91 million
Exact value

Exact value: 2906000 USD

2011-01-01 – 2011-12-31: 2906000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 79.64 million
Exact value

Exact value: 79642000 USD

2011-01-01 – 2011-12-31: 79642000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 21.91 million
Exact value

Exact value: 21908000 USD

2011-01-01 – 2011-12-31: 21908000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 57.73 million
Calculation and evidence

79642000 − 21908000 USD

Exact free cash flow: 57734000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

7 filings · 501 latest values · 501 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001525040, 1525040, edgar:1525040

Also known as AMERICAN RENAL ASSOCIATES HOLDINGS, INC., American Renal Associates Holdings, Inc.